HER-2/neu serum levels and menopausal status

被引：3

作者：

Bagli, L

Dittadi, R

Zancan, M

Panzini, I

Monti, F

Ravaioli, A

机构：

[1] AUSL Rimini, Osped Infermi, Lab Biol Oncol & Ematol, Div Oncol, I-47900 Rimini, Italy

[2] Reg Hosp, Ctr Biol Markers Malignancy, Venice, Italy

[3] Reg Hosp, Ist Oncol Romagnolo, Venice, Italy

来源：

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 2001年 / 16卷 / 01期

关键词：

D O I：

10.1177/172460080101600110

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：69 / 70

页数：2

共 8 条

[1] c-erbB-2 in serum of patients with breast cancer [J].

Harris, L ;

Luftner, D ;

Jäger, W ;

Robertson, JFR .

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1999, 14 (01) :8-15

[2]

Meden H, 1997, ANTICANCER RES, V17, P3075

[3]

Mielke S, 1997, ANTICANCER RES, V17, P3125

[4] INVITRO AND INVIVO RELEASE OF SOLUBLE ERBB-2 PROTEIN FROM HUMAN CARCINOMA-CELLS [J].

MORI, S ;

MORI, Y ;

MUKAIYAMA, T ;

YAMADA, Y ;

SONOBE, Y ;

MATSUSHITA, H ;

SAKAMOTO, G ;

AKIYAMA, T ;

OGAWA, M ;

SHIRAISHI, M ;

TOYOSHIMA, K ;

YAMAMOTO, T .

JAPANESE JOURNAL OF CANCER RESEARCH, 1990, 81 (05) :489-494

[5] THE TYPE-I GROWTH-FACTOR RECEPTORS IN HUMAN BREAST-CANCER [J].

RAJKUMAR, T ;

GULLICK, WJ .

BREAST CANCER RESEARCH AND TREATMENT, 1994, 29 (01) :3-9

[6] ERBB2 oncogene in human breast cancer and its clinical significance [J].

Révillion, F ;

Bonneterre, J ;

Peyrat, JP .

EUROPEAN JOURNAL OF CANCER, 1998, 34 (06) :791-808

[7]

Shak S, 1999, SEMIN ONCOL, V26, P71

[8] Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein [J].

Yamauchi, H ;

ONeill, A ;

Gelman, R ;

Carney, W ;

Tenney, DY ;

Hosch, S ;

Hayes, DF .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) :2518-2525

← 1 →